Castle Biosciences Inc
(NASDAQ:CSTL)
Castle Biosciences Inc is a commercial-stage dermatological cancer company. It is focused on providing physicians and their patients with personalized, clinically actionable genomic information to make more accurate treatment decisions. The product portfolio of the company includes Cutaneous Melanoma, DecisionDx-Melanoma, DecisionDx-CMSeq, and DecisionDx-PRAME among others.
top performing CSTL trades
Recent Trades
Largest Trades
Top Performing
Largest Traders
Most Active Traders
Recent Trades
View the most recent Castle Biosciences trades made by congress members.
 Josh GottheimerHouse (D-NJ) | $1K - $15K | stock | Sale | Apr 17, 2022 | Mar 15, 2022 | House |